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NCDs: A Global Threat to Sustainable 
Development
Dear Colleagues:
I n September 2015, the United Nations General Assembly will set the Sustainable Development Goals (SDGs) for 2030, 
including the goal of ensuring healthy lives 
and promoting well-being for everyone at all 
ages.  In low- and middle-income countries 
(LMICs), noncommunicable diseases (NCDs), 
including heart disease, stroke, cancer, 
diabetes and injuries, are increasing rapidly 
and cannot be ignored. 
In 2013, 60% of global deaths (35 million) were caused by NCDs, and 80% of those deaths (28 
million) occurred in LMICs. Most NCD-related deaths (8 million), were among people under 
60 years old. NCDs result in tremendous health care costs, lost productivity, and collectively 
undermine SDGs. For example, in 2001 hypertension cost $370 billion (10% of annual 
healthcare expenditures). Over the next decade, if unattended, indirect costs could be as high 
as $3.6 trillion annually. 
It is important for our relationships with these countries that we partner with them to 
better prevent and control these leading causes of disease, disability and death. We have a 
tremendous opportunity to slow the growth of NCDs by continuing to work with Ministries of 
Health and other partners, and adapting and applying well-tested sustainable approaches to 
NCD prevention and control.  
The World Health Organization has established an NCD Global Monitoring Framework with 9 
targets to reduce NCD deaths by 25% by 2025. To meet these targets, the importance of having 
accurate data cannot be overstated. Efficient monitoring and surveillance are cornerstones to 
track progress. Systematic monitoring of risk factors and vital records is essential.  With accurate 
data and analysis, countries will be able to prioritize essential resources and make sound policy 
decisions. 
As we have seen with the response to Ebola and other infectious disease outbreaks, having 
Field Epidemiology Training Programs in countries is critical to disease prevention and control. 
There are many lessons learned from preventing the spread of infectious diseases and providing 
treatment and access to health care that are relevant to how we manage NCDs. 
CDC will continue to develop and promote technical packages such as MPOWER for tobacco 
control and THRIVES for violence against children; these are good investments that will have a 
far-reaching impact.
This issue of Updates from the Field focuses on NCDs and demonstrates CDC’s commitment to 
working with partners to address this global priority.  Together we can make a difference.  
Tom Frieden, MD, MPH 
Director, U.S. Centers for Disease Control and Prevention
Summer 2015, Issue 19
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WHO’s Global Monitoring Framework Tracks Progress in NCD 
Prevention and Control 
Submitted by: Leanne Riley, MSc, Surveillance and Population-Based Prevention Unit, and Douglas Bettcher, MD, PhD, MPH, Director, 
Prevention of NCDs Department, WHO-Geneva, Switzerland 
N oncommunicable Diseases (NCDs) are the leading cause of death in the world. Four NCDs — cardiovascular disease, cancer, chronic lung diseases and diabetes –  
are responsible for two-thirds of all deaths worldwide. 
Premature deaths from NCDs can be prevented by appropriate 
policy changes and active engagement in health and other 
sectors. Effective action will save millions of lives and avoid 
countless suffering.
Following the Political Declaration on the Prevention and Control of 
Noncommunicable Diseases adopted by the United Nations General 
Assembly in 2011, the World Health Organization (WHO) developed 
a Global Monitoring Framework (GMF) to enable tracking of progress 
in preventing and controlling these major NCDs and their key 
risk factors – tobacco, harmful use of alcohol, unhealthy diets and 
physical inactivity.
Framework targets and indicators
In May 2013, the 66th World Health Assembly adopted the GMF for 
tracking the prevention and control of NCDs.  The GMF includes a 
set of 25 indicators to monitor trends and assess progress made by 
countries and regions in the implementation of their national NCD 
strategies and plans. These indicators address three areas of focus: 
1) mortality and morbidity; 2) risk factors; and 3) national system 
response. Nine voluntary global targets have been selected from 
the 25 indicators in the GMF and are aimed at combatting global 
mortality from the four main NCDs, accelerating action against the 
leading risk factors for NCDs, and strengthening national health 
system response (Figure 1). The 9 voluntary global NCD targets 
include: 
• A mortality target – a 25% reduction in premature mortality 
from NCDs by 2025; 
• Six risk factor targets (harmful use of alcohol, physical inactivity, 
dietary salt/sodium intake, tobacco use, raised blood pressure, 
diabetes and obesity); and 
• Two national systems targets (drug therapy and counselling to 
prevent heart attacks and strokes), and essential NCD medicines 
and technologies to treat major NCDs.
These global targets have been set for 2025. They are significant 
and attainable, and when achieved, they will represent major 
accomplishments in the reduction of NCD risk factors globally.  
Framework goals and guidelines for measuring 
progress
The GMF is expected to facilitate progress and provide the 
foundation for advocacy, raising awareness, reinforcing political 
commitment, and promoting global action in preventing and 
controlling NCDs.  
WHO has produced guidance for countries on how to measure 
and report on the indicators included in the GMF guidance.  WHO 
is mandated to prepare regular updates on the progress towards 
achieving the 9 global NCD targets in relation to the 25 indicators 
included in the GMF.  Member States are requested to submit data 
to WHO on a regular basis to enable analysis of the global status of 
NCD targets and indicators.  WHO will continue to produce estimates 
for each country that are comparable across all Member States.  
For further information on the WHO NCD Global Monitoring 
Framework please visit http://www.who.int/nmh/global_
monitoring_framework/en/ or contact Ms. Leanne Riley 
at rileyl@who.int.
A 25% relative reduction in risk of
premature mortality from cardiovascular
disease, cancer, diabetes or chronic
respiratory diseases
 
At least a 10% relative
reduction in the harmful
use of alcohol
 
A 10% relative reduction
in prevalence of insufficient
physical activity
 
A 25% relative reduction
in prevalence of raised
blood pressure or contain
the prevalence of raised
blood pressure
 
At least 50% of eligible
people receive drug therapy
and counselling to prevent
heart attacks and strokes



















   
 
9 global NCD targets to be attained by 2025 (against a 2010 baseline)
For complete WHO NCD Global Monitoring Framework please visit 
http://www.who.int/nmh/global_monitoring_framework/2013-11-06-who-dc-c268-whp-gap-ncds-techdoc-def3.pdf?ua=1.
Figure 1.  Global Monitoring Framework
3 of 16
Highlights of Investigations
Updates from the Field: Summer 2015, Issue 19
Sexual Violence Against Children: 
A Global Problem
Submitted by: Katherine Lean, MPH - CDC
S exual violence against children is a worldwide problem. Violence against children often hides in the shadows of a community due to the shame and/or fear associated with it. 
Data help us bring the problem out of the shadows and understand 
more about which prevention strategies can be sustained in these 
communities. U.S. Centers for Disease Control and Prevention (CDC)  
created the Violence Against Children Surveys (VACS) to collect data 
that measure the extent of physical, sexual, and emotional violence 
against children. 
How VACS works
Through the global public-private partnership called Together for 
Girls (TfG), CDC and the United Nations Children’s Fund (UNICEF) 
assist host countries in the collection of data from households in their 
communities. TfG and its members then help the host countries use 
the information to plan responses and actions that make a difference.
Recent findings
Recent data focus on lifetime childhood sexual violence (before age 
18 years) among females and males aged 18-24 in seven countries 
(Swaziland, Tanzania, Kenya, Zimbabwe, Malawi, Haiti, and Cambodia) 
between 2007 and 2013. 
The data show that at least 1 in 4 females 
and 1 in 10 males have experienced 
some form of childhood sexual violence 
in the majority of countries studied. 
Swaziland and Zimbabwe reported 
the highest rates of all kinds of sexual 
violence among females (38% and 33%, 
respectively), while Cambodia reported 
the lowest rates for both females (4%) 
and males (6%). Among those who 
reported being a victim of childhood 
sexual violence, few received healthcare, 
legal/security aid, or counseling support. 
At least 25% of females 
experienced some form of 
childhood sexual violence in the 
majority of the countries studied.
The bigger picture  
Preventing sexual violence is an important 
component of many disease prevention 
strategies. Being a victim of sexual violence 
puts a child at risk for HIV, sexually transmitted 
infections, heart disease, cancer, diabetes, 
tobacco use, alcoholism and drug addiction, 
depression, poor social relations, and low self-
esteem, among others. CDC, PEPFAR and others 
are studying the link between sexual violence 
and HIV to better understand this relationship.
Next steps
Country-specific prevention and response initiatives are a 
necessary next step once the VACS data have been collected. 
More than 10% of males 
experienced sexual violence 
in most of the countries 
studied.
CDC developed a resource called THRIVES , which includes evidence-
based programs and policies for health, education, mental health, 
social services, and justice systems that countries can use to prevent 
and respond to violence against children. The programs and policies 
described in THRIVES are supported by research conducted by CDC, 
PEPFAR, WHO and UNICEF.
Together for Girls Partnership Members
Centers for Disease Control and 
Prevention (CDC)
The United States Agency for 
International Development (USAID)
The President’s Emergency Plan 
for AIDS Relief (PEPFAR)
The United Nations Children’s 
Fund (UNICEF)
The Joint United Nations 
Programme on HIV/AIDS (UNAIDS)
CDC Foundation
The World Health Organization (WHO) 
The U.S. Department of State
The United Nations Entity for Gender 
Equality and the Empowerment 
of Women (UN Women)
The United Nations Population 
Fund (UNFPA)
Grupo ABC
Becton, Dickinson and Company
For the full report and the study details, please visit 
http://www.cdc.gov/mmwr.
For more information about the Violence Against Children Survey, 
please visit http://www.cdc.gov/violenceprevention/vacs/index.html.  
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Vietnam Field Epidemiology Training Program: Measuring the Impact 
of Vietnam’s Universal Helmet Law in Ho Chi Minh City 
Submitted by: Ninh Thi Ha, MPH, MHSP - Vietnam FETP Resident
T he world is rapidly motorizing and the need for international road safety is greater than ever before. According to the World Health Organization (WHO), 
about 1.2 million people die each year as a result of road traffic 
injuries (RTIs), with 91% of such deaths in low- and middle-income 
countries despite having only half of the world’s vehicles.  Globally, 
RTIs are the eighth leading cause of death and the number one 
cause of death among persons 15-29 years of age. In Vietnam, 
traffic crashes have an impact on the younger generation in the 
same way—traffic crashes are the leading cause of death among 
Vietnamese 15-29 years of age. Each year, approximately 14,000 
people are killed in traffic crashes in Vietnam, with a majority (78%) 
of fatal crashes involving motorcycles. 
Universal helmet law spurs increase in helmet use
Given their portability, affordability and speed, motorcycles have 
rapidly evolved as the primary mode of transportation in Vietnam.  
Unfortunately, motorcyclists account for approximately 59% of 
Vietnam’s road traffic injuries. As part of an effort to reduce the 
impact of RTIs, the Vietnamese Government passed a universal 
motorcycle helmet law in 2007 mandating helmet use among all 
motorcycle drivers and passengers. The policy went into effect on 
December 15, 2007, resulting in increased helmet use (from 40.1% 
to 92.5%) and a unique opportunity to further evaluate the impact 
of the policy. 
Motorcyclists on a busy street in Ho Chi Minh City.
Data shows significant reduction in injuries and 
fatalities
Vietnam’s Field Epidemiology Training Program (FETP), based in the 
Ministry of Health, was ready to respond. FETP residents are trained 
to respond to public health threats, utilizing epidemiological data 
to analyze health issues and recommend policies. Through a CDC/
TEPHINET mini-grant, Vietnam FETP residents at the Institute of 
The map of Cu Chi 
district with the 
borders to three other 
provinces, the star is 
the location of the 
regional general Cu 
Chi hospital, located 
near the intersection 
of many freeways.
Public health in Ho Chi Minh City (HCMC) are measuring the effect of 
the helmet law in reducing head injuries and deaths in the HCMC’s 
Cu Chi district. In collaboration with the regional general hospital in 
Cu Chi, the team developed a data collection tool and has abstracted 
information from patient records. Of the 18,000 records related to 
injuries, 12,000 (67%) were due to RTIs. The team also collaborated 
with the Cu Chi Preventive Medicine Center to identify 500 RTI deaths 
recorded from 21 commune health stations. 
The project is in the data analysis phase, with support provided by 
injury epidemiologists at the Vietnam Institute of Public Health and 
the U.S. Centers for Disease Control and Prevention (CDC).  Fieldwork 
to date has demonstrated a significant reduction in motorcycle 
fatalities and head injuries from 2005 to 2010. However, <3% of  
the medical charts and death certificates included information on 
motorcycle helmet use, preventing a full evaluation of the 2007 
law. There are also concerns about the proliferation of low-cost, 
uncertified helmets, thus highlighting the need for improved injury 
surveillance systems. 
This project is a great example of 
primary field data collection and 
analysis, highlighting the FETP 
contribution to policy evaluation 
and development. It also provides 
an excellent field research study that 
could be replicated and scaled up in 
other countries to address RTIs and 
other NCDs.  Plans are underway to 
convert this field experience to an 
FETP case study on using data to 
evaluate the impact of health policy. 
Ms. Van Anh, Co-principle 
investigator abstracting information 
from patient records at the regional 
general Cu Chi Hospital.
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Brazil Leads the Way to Integrating Tobacco Surveys into its 
National Surveillance System
Submitted by: Roberta Caixeta, DDS, MHSc -  PAHO; Deborah Malta, MD, PhD - MoH Brazil;  Maria Lúcia Vieira, Economist - IBGE; 
Adriana Blanco, MD, MPA - PAHO; Lazarous Mueblo, PhD, Krishna Palipudi, PhD  and Samira Asma, DDS, MPH - CDC  
I n 2008, Brazil implemented the Global Adult Tobacco Survey (GATS), a stand-alone, nationally representative household tobacco survey that uses a consistent, standardized protocol 
in participating countries.  GATS was conducted as a supplement 
of Brazil’s National Household Sample Survey (PNAD) among 
persons aged 15 years and above.  Adding GATS as a supplement 
to PNAD was a visionary step taken by Brazil, making it one of 
the first countries to embed a stand-alone topical survey into a 
general household survey, resulting in increased efficiencies in 
both time and resources.  The integrated survey generated more 
robust data on tobacco use relative to the determinants of health, 
noncommunicable diseases (NCDs), and other health metrics.
Impact of expanding National Health Survey
In 2013, Brazil also expanded the scope of its data collection by 
integrating standard Tobacco Questions for Surveys (TQS) into its 
National Health Survey (PNS), which is planned to be conducted 
every 5 years. TQS is a standard set of core questions taken from the 
GATS survey and is a component of the Global Tobacco Surveillance 
System (GTTS). It was developed by the World Health Organization 
(WHO), the U.S. Centers for Disease Control and Prevention (CDC), 
and other partners to assist countries in establishing tobacco 
control surveillance and monitoring programs. Brazil’s National 
Health Survey is an ongoing survey which produces national and 
subnational representative estimates of the health conditions and 
lifestyle risk factors among the Brazilian adult population. Due to 
methodological issues, the PNS included the population aged 18 
years and older. The integration of the TQS into the framework of 
Brazil’s ongoing national surveys serves as a mechanism to:
• Harmonize and standardize the monitoring of key tobacco 
control indicators, 
• Promote  further efficiencies, and 
• Ensure sustainable and consistent generation of data on 
tobacco use and key tobacco control measures.
According to GATS Brazil 2008, 18.2% (24.1 million) adults aged 18 
years and older (22.9% men and 13.9% women) reported current 
tobacco use.  In 2013, according to PNS, 14.7% (21.5 million) adults 
(18.9% men and 11.0% women) reported current tobacco use.  
Findings from these two surveys indicated that current tobacco 
smoking among adults in Brazil declined from 18.2% in 2008 to 
14.7% in 2013, which translates to a 19.2% relative reduction in 
current smoking prevalence. 
Model for integrated surveillance and tracking 
The model implemented by Brazil carves a new path towards 
integrated surveillance by systematically tracking tobacco use, 
NCD risk factors, and other relevant health information to develop, 
implement and evaluate public health interventions.  This method 
will enable countries to track the WHO NCD global voluntary targets. 
Brazil's model carves a new path towards integrated surveillance 
by systematically tracking tobacco use, NCD risk factors, and other 
relevant health information to develop, implement and evaluate 
public health interventions. Brazil's model is a best practice for 
other countries to consider and emphasizes the benefit of multiple 
stakeholders working together toward a common goal and finding 
innovative ways to simplify standard surveillance systems. Examples 
of such partnerships include: 
• The Instituto Brasileiro de Geografia e Estatística (IBGE), working 
with the Brazilian Ministry of Health to implement the surveys. 
This partnership has been an example for other statistics institutes 
in the region; and
• The Pan American Health Organization (PAHO), WHO and CDC 
working collaboratively to support Brazil through technical 
exchange and workshops.  
Brazil has been a pioneer in the development of the WHO Framework 
Convention on Tobacco Control. The decline in tobacco use in Brazil 
is a result of the country’s consistent commitment to implementing  
comprehensive tobacco control measures.  
For further information, please contact Dr. Roberta Caixeta at 
caixetro@paho.org.
Data show that current tobacco smoking among adults in Brazil has declined almost 
20% since 2008. Photos courtesy of David Snyder©.
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Bloomberg Data for Health Initiative Aims to Impact 1.2 Billion People
Submitted by: Mick Ballesteros, PhD, Shelly Bratton, MPH, Sam Notzon, PhD, and David Sugerman, MD, MPH - CDC
F ocused public health action relies on accurate vital statistics which are created when births and deaths are officially reported to the authorities. For deaths, such 
reporting also includes notification of the cause of death. Despite 
significant advances in technology and global information 
systems worldwide, each year 35 million deaths go unreported 
and therefore uncounted, with no cause of death recorded. Many 
of these unrecorded deaths occur in low- and middle-income 
countries, where policymakers and public health officials often lack 
the essential public health data and training needed to plan and 
implement public health strategies.
According to the World Health Organization (WHO), “When deaths 
go uncounted and the causes of death are not documented, 
governments cannot design effective public health policies or 
measure their impact.”  
Providing tools and assistance 
To address this challenge, the U.S. Centers for Disease Control and 
Prevention (CDC), through the support of Bloomberg Philanthropies 
and the Australian government, has begun working on the 
Bloomberg Data for Health initiative.  This initiative seeks to partner 
with governments, aid organizations and public health leaders in 20 
low- and middle-income countries by providing tools and systems to 
improve data collection systems and offering assistance in increasing 
the use of data to prioritize health issues, provide resources, inform 
policy decisions, and measure success.  
CDC staff serve as scientific and technical experts on the initiative’s 
three projects, which aim to:
1. Strengthen Birth and Data Registration Systems and Improve 
Information on Cause of Death - Many countries do not have 
adequate systems in place to compile vital statistics. An 
estimated two-thirds of deaths around the world are never 
registered, and when deaths are registered there are challenges 
with documenting the causes, including deaths from 
noncommunicable diseases (NCDs) such as heart disease, cancer, 
and diabetes.  CDC’s National Center for Health Statistics will 
provide technical expertise and help develop a sustainable 
infrastructure for capturing this information. 
2. Create Best-in-Class Mobile Phone Risk Factor Surveys for 
Noncommunicable Diseases - Approximately 75 percent of all 
deaths worldwide are from NCDs —chronic diseases (such as 
heart attacks, stroke, cancer and diabetes), injuries and 
environmental health factors.  CDC, in collaboration with 
governments and other Bloomberg Philanthropies Data for Health 
partners, will determine the feasibility, quality, validity, and 
reliability of using mobile phone surveys as an interim and 
complementary measure to traditional face-to-face household 
surveys. If found to be valid, this potentially less costly survey 
methodology would allow Ministries of Health to more frequently 
assess self-reported risk factors of NCDs, enact responsive policies, 
and more closely monitor the effectiveness of implementing 
policies and programmatic interventions.
3. Improve Capacity to Use Health Data to Inform Policy 
Development - Many low- and middle-income countries 
infrequently use public health data to drive policy decisions, 
partially due to a shortage of epidemiologists with specialized 
health policy writing and communication skills, and use of 
platforms to disseminate scientific findings.  CDC’s Field 
Epidemiology Training Program (FETP) and National Public Health 
Institute (NPHI) will: 1) provide specialized training utilizing case 
studies; 2) deliver courses on scientific writing and 
communication for in-country FETP residents; and 3) develop 
country-level data use committees and national public health 
bulletins. These strategies will improve the capacity in Ministries 
of Health to use health data to inform policy development.
Using innovation and data to inform decision-making
Bloomberg Philanthropies’ Data for Health initiative demonstrates its 
data-driven approach and the Australian government’s commitment 
to using innovation to drive government decisions. This project will 
impact more than 1.2 billion people who live in countries that will 
have improved capacity to use data to inform critical public health 
decisions.
In addition to CDC, other partners in the initiative include: 
The University of Melbourne, Australia; The Union North America; 
Johns Hopkins Bloomberg School of Public Health; WHO; and the 
CDC Foundation.
CDC is grateful to Bloomberg Philanthropies and the Australian 
government for funding this initiative that will gather vital health 
data, target resources and save lives.
For further information, please contact Cho Ling, Senior Program 
Officer, CDC Foundation at Cling@cdcfoundation.org.
Village chiefs complete registers in 
Malawi. This is an example of the 
work that will be implemented 
through the Bloomberg Data for 
Health initiative.
... continued on page 7
Civil registration officer works with 
mothers to complete birth notification 
forms at a maternal child health clinic 
in East Africa and is an example 
of the documentation that will be 
implemented through the Bloomberg 
Data for Health initiative.
Local civil registration officer teaching 
a health officer in East Africa how to 
complete a birth notification form. 
This illustrates the kind of training 
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Promoting Sustainable and Integrated NCD Surveillance
Submitted by: Isabel Garcia de Quevedo, MSPH, Lauren Bartell, MPH, Jeremy Morton, MS - CDC; Edouard Tursan d'Espaignet, PhD - WHO; 





TQS is a cost 
effective and 
sustainable option 
to monitor the 
tobacco epidemic. 
As of 2014, 49 
countries have 
integrated TQS. 
The target is to 
apply TQS in 70 
countries by 2016.
T obacco use is a leading cause of preventable death in the world and a risk factor for four major NCDs: cancer, cardiovascular disease, diabetes, and chronic respiratory 
diseases. About 6 million people die annually from tobacco, and 
if nothing is done to reverse or halt the epidemic, tobacco-related 
deaths could rise to 8 million by 2030. Additionally, exposure to 
secondhand smoke currently kills more than 600,000 nonsmokers 
each year. The burden of tobacco use is high, but there are 
effective solutions that have been proven to work. Country 
interventions that align with the World Health Organization 
Framework Convention on Tobacco Control (WHO FCTC) 
articles – especially its demand reduction measures that WHO 
has badged under the acronym (mPOWER)— have demonstrated 
tobacco use declines, resulting in lives saved. Accelerating these 
evidence-based interventions will only further reductions in 
tobacco use, which can have implications on other areas of 
public health including reproductive health, communicable and 
noncommunicable diseases (NCDs).
Efficiencies of integrating TQS into Surveys
Launched in-partnership with WHO and U.S. Centers for Disease 
Control and Prevention (CDC), Tobacco Questions for Surveys (TQS) 
is a list of 22 survey questions grouped according to the mPOWER 
classification that ensures consistency in reporting results with the 
Global Adult Tobacco Survey. TQS offers flexibility through seamless 
integration into national and international surveys, increasing the 
pool of reliable results and quality estimates. TQS is a surveillance 
tool that can help integrate data on tobacco use with data on 
NCDs and risk factors. Integration can also allow for financial and 
human resources to be shared, increasing efficiency. Continuous 
monitoring of tobacco use can assist countries in tracking targets 
and indicators in accordance with the WHO Global Monitoring 
Framework (GMF). The GMF has a specific tobacco target of a 30% 
relative reduction in current tobacco use by 2025 (using 2010 as 
baseline). 
TQS is a component of the Global Tobacco Surveillance System 
(GTSS), which was launched in 1999 to help countries generate 
reliable, accurate, and comparable data on the burden of tobacco 
and measure the progress of efforts over time. GTSS is a set of 
surveillance tools that have been internationally recognized for their 
standardization, rigor, and accuracy in systematically monitoring 
youth and adult tobacco use. This system generates nationally 
representative data on tobacco use at a global level, which can help 
to guide policies and programs. 
... continued on page 9
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... continued from page 8
Promoting Sustainable and Integrated NCD Surveillance
TQS features include:
• Provides a sustainable way to collect continuous tobacco use data
• Ensures consistency in reporting results across countries
• Offers flexibility through seamless integration into national and 
international surveys
• Increases the pool of reliable, high-quality data on tobacco use 
• Is cost-effective 
• Is currently available in Arabic, Chinese, English, French, 
Portuguese, Russian, and Spanish
Support of Global Partners
A TQS Global Alliance, which includes partners from various 
organizations, was established and aims to promote the integration 
of TQS into surveys. The alliance is made up of representative from 
various international surveillance systems; research organizations 
(e.g., Academia and Public Health Institutes); and countries (e.g., 
National statistical agencies or Ministries of Health) that recognize 
the value of strengthening systematic monitoring and surveillance of 
tobacco use and key tobacco control measures. In 2013, a target was 
set to apply TQS in 70 countries by 2016. TQS was integrated into the 
WHO STEPwise approach to Surveillance (STEPS) core questionnaire. 
STEPS is  a simple, standardized method for collecting, analyzing and 
disseminating data in WHO member countries. The Demographic and 
Health Survey (DHS) also recently included a few TQS questions into 
their core Man’s questionnaire.
Successful TQS Integration Examples 
Bangladesh WHO STEPS (NCD Risk Factor Survey), 2010
Brazil National Health Survey (PNS), 2013
Cameroon Multiple Indicator Cluster Survey (MICS), 2014
China Behavioral Risk Factor Surveillance System (BRFSS), 2011
Egypt WHO STEPS (NCD Risk Factor Survey), 2011
Kazakhstan Almaty city initiative, 2013
Pakistan UNODC National Health Behaviour Survey, 2012
Russian 
Federation Reproductive Health Survey (RHS), 2011
Thailand Cigarette Smoking and Alcohol Drinking Behavior Survey (CSAD), 2011
Turkey
National Health Survey (NHS)
• First country to integrate TQS into a 
national health survey
• Completed 4 rounds, 2008-2014
Turkey field worker 
conducting household 
tobacco use survey. 
Bangladeshi field 
worker collecting 












preparing to go 
into the field 
to collect data 
with their map.
Monitor tobacco use & prevention policies 
Protect people from tobacco smoke 
Offer help to quit tobacco use 
Warn about the dangers of tobacco 
Enforce bans on tobacco advertising, promotion, & sponsorship 
Raise taxes on tobacco 
For more information on global tobacco control and GTSS, 
please visit http://www.cdc.gov/tobacco/global/ or  contact 
Isabel Garcia de Quevedo at vpr5@cdc.gov.
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Regional Reference Center and Costing Tool Aim to Increase 
Capacity for Cancer Registration in the Caribbean
Submitted by: Michelle O’Hegarty, PhD, Rachael Joseph, VMD, Mona Saraiya, MD, and Florence Tangka, PhD - CDC
C ancer is a significant public health burden in the Caribbean region, as it is in many other parts of the world. In 2012, there were approximately 91,000 new 
cancer cases and 53,000 cancer-related deaths in the region 
(GLOBOCAN, 2012).  Quality population-based cancer registries 
are the primary source of cancer surveillance data and are 
essential for planning, monitoring, evaluating and improving 
cancer prevention and control efforts. Fewer than 10 Caribbean 
member-states have a population-based cancer registry, and 
only two of these meet the data quality standards for inclusion in 
international statistics. As a result, the availability of population- 
based cancer registry data in the Caribbean is limited.
Establishing a regional reference center
The Global Initiative for Cancer Registry Development (GICR), led 
by the International Agency for Research on Cancer (IARC) (in 
partnerships with several international organizations), aims to 
improve population-based cancer registries worldwide through 
the establishment of six regional reference centers, termed IARC 
Hubs. U.S. Centers for Disease Control and Prevention (CDC) and the 
National Cancer Institute are collaborating with the North American 
Association of Central Cancer Registries, IARC and the Caribbean 
Public Health Agency (CARPHA) to develop and implement a 
regional Hub in the Caribbean. Key activities for the Hub are to: 
• Build and sustain Caribbean member states’ capacity for 
cancer registration, 
• Provide training and technical support, 
• Promote networking among cancer registries, and 
• Foster collaborative research within the region. 
An Epidemic Intelligence Service Officer assigned to CDC’s Office 
of International Cancer Control will also assist with Hub activities 
by evaluating cancer registries in the region. The Hub will be located 
at CARPHA headquarters in Port-of-Spain, Trinidad and Tobago, 
with an expected launch in the fall of 2015.
Developing a costing tool 
Limited knowledge of the cost to establish, operate and improve 
population-based cancer registries in low- and middle-income 
countries is a key challenge of GICR. The most comprehensive 
estimates of the cost of cancer registration activities are available 
from the economic evaluation of the central cancer registries in 
the U.S. Cost estimates from established registries in high-income 
countries cannot be extrapolated to low- and middle-income 
countries due to differences in the infrastructure available for 
collecting and reporting data. Building upon experience gained 
from evaluating U.S. cancer registries, CDC, in collaboration 
with IARC and RTI International, is developing a standardized 
Staff from the Caribbean Public Health Agency, the International Agency for Research 
on Cancer, U.S. National Cancer Institute, the North American Association of Central 
Cancer Registries and CDC during the first planning meeting for the Caribbean Hub 
at the CARPHA Headquarters, Port-of-Spain, Trinidad & Tobago, January 21, 2015. 
International Cancer Registry Costing Tool (InCanRegCosting tool) 
to assess the cost of cancer registration in low- and middle-income 
countries, including the Caribbean. Cost assessment pilot testing 
using the InCanRegCosting tool is currently under way in Barbados, 
Colombia, Kenya, Uganda and India. Barbados is unique because 
it has three registries (Heart, Stroke and Cancer). Key questions 
assessed during the pilot testing include the following:
• What are the funding sources for cancer registries?
• How much does it cost to register a cancer case?
• What is the cost per case for specific registry activities?
• What factors impact the efficiency of operating a registry?
“Establishment of an evidence base for the cost of cancer registration 
and specific registry activities will give decision makers information 
to more accurately gauge the budget needs of existing registries, 
and it will give them the funding that may be necessary to improve 
data quality, support registry activities and increase efficiency,” 
said Dr. Florence Tangka, Health Economist in the Division of 
Cancer Prevention and Control, CDC. Cost data collected using the 
InCanRegCosting tool will provide valuable information to guide 
decisions and improve cancer registration globally. 
For further information, contact: Dr. Michelle O’Hegarty at 
mohegarty@cdc.gov.
CDC and the Barbados National Registry staff. From left to right: Mr. Stewart-Andre 
Wilkinson, Dr. Michelle O’Hegarty, Dr. Florence Tangka, Ms. Karen Greene, 
Ms. Jacqueline Campbell, Mrs. Shelly-Ann Forde, Dr. Rachael Joseph, Ms. Ashley 
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Public Health Experts Tackle Major Global Problem: Hypertension 
Submitted by: Pragna Patel, MD, MPH - CDC, and Donald J. DiPette, MD - University of South Carolina School of Medicine, Columbia, SC 
H ypertension, a leading cardiovascular disease risk factor, is a global health concern affecting more than one billion people worldwide. The U.S. Centers for 
Disease Control and Prevention (CDC), joined by leading global 
experts, confronts this problem by standardizing the medical 
treatment of hypertension and increasing access and affordability 
of medications. This approach is inspired by successful treatment 
models for infectious diseases. 
Noncommunicable diseases 
(NCDs) are responsible for 
almost three-quarters of all 
deaths worldwide. Over the 
past decade, cardiovascular 
disease has become the 
single largest cause of death 
worldwide, representing 
nearly 30% of all deaths 
and approximately half of 
NCD deaths. Hypertension 
is a leading risk factor for 
cardiovascular disease and 
is responsible for over nine 
million preventable deaths 
globally each year. Despite advances in health education and 
medical treatment, hypertension persists as a major public health 
issue and significant cause of morbidity and mortality. 
While hypertension is an ongoing concern in high-income 
countries, it is also a major concern in low- and middle-income 
countries. For example, in sub-Saharan Africa, the percentage of the 
general adult population affected by hypertension currently ranges 
from 16-40%, but is projected to increase to approximately 70% by 
the year 2025 if nothing is done. 
Reason for action
If we do nothing to address this problem, the economic impact 
will be substantial, threatening national and global development 
agendas. A recent report predicts that the cost of inaction on 
cardiovascular illness will increase related healthcare expenditure 
by 22% (US$1,044 billion) by 2030. Given these sobering statistics, 
the WHO NCD Global Monitoring Framework (GMF), endorsed at 
the World Health Assembly in May 2013, included the following 
global voluntary targets related to the prevention and treatment of 
hypertension by 2025: 
• A 25% reduction in the prevalence of raised blood pressure
• A 30% reduction in salt intake or a reduction of mean 
population intake of salt to < than 5 grams per day
• At least 50% of eligible people receiving drug therapy and 
counselling to prevent heart attacks and strokes
Addressing the problem 
CDC in collaboration with the Pan American Health Organization 
(PAHO) and other partners launched the Global Standardized 
Hypertension Treatment Project (GSHTP) in 2011. This project 
involves the development and implementation of a framework for 
standardizing the medical treatment of hypertension and increasing 
access and affordability of medications. The GSHTP is inspired 
by successful treatment models for global tuberculosis and HIV 
management. Central elements include a structured treatment 
approach with a core set of medications, improving medication 
procurement, standardized treatment protocols with targets, and 
patient monitoring. The project design aims are feasible and flexible, 
can be applied worldwide and complement existing hypertension 
guidelines. In 2014, a successful pilot was launched in Barbados, with 
expansion to St. Lucia and Colombia planned for the coming year.
Additionally, CDC is leveraging the current President’s Emergency 
Plan for AIDS Relief (PEPFAR) infrastructure of US-funded HIV 
care delivery sites in Malawi to include management of NCDs, 
specifically hypertension.  This approach will increase awareness in 
African communities about NCDs and provide a platform for NCD 
management over the long-term. 
An online toolkit that includes a hypertension webinar is available for 
health care professionals interested in incorporating components of 
GSHTP to enhance hypertension treatment. 
For further information, contact Dr. Pragna Patel at plp3@cdc.gov.
A patient getting his blood pressure checked at the vital signs station in Malawi.  
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Cigarettes and Beyond: Testing Tobacco Products Around the World 
Submitted by: Patricia Richter, PhD, DABT - CDC, and Gemma Vestal, JD, MPH, MBA, RN - WHO
T obacco use causes 1 in 10 deaths among adults worldwide. The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) was 
adopted in 2003 and fully implemented in 2005. The goal of FCTC 
is to protect present and future generations from the devastating 
health, social, environmental and economic consequences of 
tobacco consumption and exposure to tobacco smoke. Article 9 
of the FCTC focuses on the regulation of tobacco products and 
requires laboratory methods to be developed to measure harmful 
chemicals in tobacco and tobacco smoke.
WHO Tobacco Laboratory Network
To develop the needed laboratory methods, the WHO Tobacco 
Laboratory Network (TobLabNet) was created. TobLabNet is a global 
network of more than 30 laboratories, located in all six WHO regions, 
that work together to create methods to measure harmful chemicals 
in tobacco and tobacco smoke. Having data on levels of harmful 
chemicals in tobacco products in their countries helps nations when 
making decisions on how to regulate tobacco products and protect 
the health of their citizens. The results of TobLabNet’s work are 
published in the scientific literature, and the laboratory methods are 
available to researchers and public health decision makers on WHO’s 
website.
June 3-5, 2015 TobLabNet meeting at National Institute for Public Health and the 
Environment (RIVM), The Netherlands. CDC scientists and colleagues from Burkina 





smoke used to 
measure toxic and 
cancer-causing 
chemicals. 
CDC has been a full member of TobLabNet from its beginning.  
CDC scientists have participated in studies to develop methods to 
measure nicotine, humectants (chemicals that absorb and retain 
moisture), and toxic and cancer-causing chemicals like ammonia 
and benzene. The laboratory work is done with automated smoking 
machines that puff cigarettes in a consistent manner to create the 
smoke measured by the scientist. While no person smokes like a 
machine, information gained from using a common laboratory 
method and automated smoking machines helps laboratories 
validate methods and produce results that can be compared to 
other laboratories.
Increased use of Electronic Nicotine Delivery systems
Initially the focus of TobLabNet was on traditional cigarettes 
because they are the most common way tobacco products are 
used, but recent attention has been turned to the other tobacco 
products that people use to consume nicotine.  A class of tobacco 
products that is increasing in use is “Electronic Nicotine Delivery 
systems (ENDS),” which include electronic cigarettes, also known 
as e-cigarettes.  Initially e-cigarettes were designed to resemble 
the size and shape of a cigarette, but newer products resemble 
cigars or hookahs (water pipes); other ENDS are large and have 
refillable tanks. ENDS differ from traditional tobacco products by 
using a battery to produce a cloud of humectant particles. The 
cloud of particles, or “vapor,” usually contains nicotine and flavored 
chemicals.  E-cigarettes are available  in most countries. In the 
United States, CDC surveys have found that the use of e-cigarettes 
by middle and high school students is rising at a concerning rate.  In 
addition to traditional tobacco products like cigarettes, cigars, and 
smokeless tobacco, CDC scientists are also studying e-cigarettes and 
exposure to e-cigarette vapor.  CDC scientists and TobLabNet are 
moving quickly to develop methods that will allow the chemicals 
in e-cigarette liquid and e-cigarette vapor to be measured and 
evaluated.
For further information, contact: Dr. Patricia Richter at pir1@cdc.gov. 
Electronic cigarette and liquid nicotine.
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Did you know? ...
 X More than 35 million people die from NCDs 
each year worldwide. More than 80% of NCD- 
related deaths are in low- and middle-income 
countries. Nearly one-third of those deaths 
are among people under the age of 60.
 X High blood pressure is responsible for over 
9 million preventable deaths globally each 
year. Of the 1.1 billion people who have 
hypertension, over 47% are not aware that 
they have it, and of the 583 million that are 
aware, only 35% are on treatment.
 X Approximately 6 million people die each 
year from tobacco use. This figure is expected 
to rise to more than 8 million by 2030.
 X 8.2 million cancer-related deaths occurred 
in 2012. The number of new cases is expected 
to rise by about 70% over the next 2 decades.
 X About 347 million people worldwide have 
diabetes, which can be traced back to rapid 
increases in overweight, including obesity and 
physical inactivity.
 X 1.5 billion adults 20 years of age and older, 
were overweight in 2008. Nearly 43 million 
children under 5 years old were overweight 
in 2010.
 X 35 million deaths go uncounted worldwide 
with no cause of death recorded. Systematic 
monitoring of vital records and risk factors is 
essential. 
 X Globally, more than nine people die every 
minute from injuries or violence —that's 
5.8 million people each year. The three leading 
causes of injury and violence-related 
deaths are: 
 - Road traffic incidents 600,000
 - Suicides 844,000
 - Homicides 600,000
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Working Together to Advance NCD Prevention and Control Globally 
The global community has the 
chance to change the course of 
the NCD epidemic.  
 
                                                  WHO Director-General Dr. Margaret Chan
The U.S. Centers for Disease Control 
and Prevention (CDC), is working 
collaboratively with WHO, PAHO, 
World Bank, and Ministries of 
Health and other partners to 
provide vision and direction 
in preventing premature 
deaths and disabilities 
due to NCDs, injuries, and 
environmental health 
hazards.  CDC’s Global NCD Program 
advances a coordinated global 
approach to NCD prevention and 
control by:
 X Strengthening surveillance, 
monitoring, evaluation and 
information systems;
 X Expanding the evidence base and 
developing and disseminating technical 
packages for effective prevention and control  
interventions; 
 X Enhancing workforce capacity for integrated, systematic 
training and technical exchange; 
 X Leveraging external partnerships and resources;
 X Coordinating with other CDC offices engaged in global NCD activities; and
 X Increasing NCD awareness and support through strategic communication.
To learn more, please visit: http://www.cdc.gov/globalhealth/ncd/default.htm 
or contact Dr. Samira Asma, Chief, Global NCD Program, CDC  sea5@cdc.gov.
Graphic of WHO NCD targets, 
courtesy of WHO
